News
As CEO of Olon's French entities, Jérôme Bédier will lead the integration of French CDMO capabilities within Olon Group and ...
2mon
GlobalData on MSNLantheus acquires radiopharma CDMO Evergreen for up to $1bnUS-based radiopharmaceutical company Lantheus has announced a definitive agreement to acquire clinical-stage radiopharma ...
AGC Biologics announces a new dedicated Cell and Gene Technologies Division, providing resources for this market lacking technical CDMO expertise. AGC Biologics is investing and growing in a ...
CHASKA, Minn., April 22, 2025 (GLOBE NEWSWIRE) -- Lifecore Biomedical, Inc. (NASDAQ: LFCR) (“Lifecore”), a fully integrated contract development and manufacturing ...
For a second time in less than a month, a new CDMO has uncloaked. This time, Meribel Pharma Solutions is gracing the stage after its financial backer snapped up a string of production facilities ...
and OSLO, Norway, April 9, 2025 /PRNewswire/ -- PharmaLogic Holdings Corp. ("PharmaLogic" or "the Company"), a leading contract development and manufacturing organization (CDMO) specializing in ...
Out of the shadows, new CDMO Artis BioSolutions has decloaked on a mission to tackle the tricky production process for advanced therapeutics. Artis officially emerged from stealth on Wednesday ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results